This binding results in an increase in the pro‐cancer BIRC5‐202 isoform and a decrease in the anti‐cancer BIRC5‐203 isoform, promoting gastric cancer progression and chemotherapy resistance.135. Here, BIRC5 is linked to gastric cancer.